Tonix Pharmaceuticals Holding Corp. — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Tonix Pharmaceuticals filed an 8-K on October 15, 2026, disclosing Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). The filing document itself contains no specific financial data, dollar amounts, counterparty names, dates of transactions, or quantified business changes—only metadata and XBRL formatting files. The actual substantive disclosures are not reproduced in this filing header.
Why this rating
8-K filing is routine periodic disclosure. No concrete business events, financials, or metrics disclosed here to assess materiality relative to $271.4M market cap.
Extracted items
- 2.02 results / earnings
- 8.01 other event
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.